康泰生物：子公司与加纳疫苗企业签署PCV13技术转移协议

Core Viewpoint - Kangtai Biological's subsidiary, Minhai Biological, has signed a cooperation agreement with a vaccine company in Ghana to license, supply, and transfer technology for a "dual carrier" 13-valent pneumonia vaccine intermediate solution [1] Group 1 - The collaboration focuses on the African market, primarily West and Central Africa [1] - The partnership aims to engage with international organizations such as GAVI and UNICEF [1]